[go: up one dir, main page]

AU2003256157A1 - Oral dosage forms of water insoluble drugs and methods of making the same - Google Patents

Oral dosage forms of water insoluble drugs and methods of making the same

Info

Publication number
AU2003256157A1
AU2003256157A1 AU2003256157A AU2003256157A AU2003256157A1 AU 2003256157 A1 AU2003256157 A1 AU 2003256157A1 AU 2003256157 A AU2003256157 A AU 2003256157A AU 2003256157 A AU2003256157 A AU 2003256157A AU 2003256157 A1 AU2003256157 A1 AU 2003256157A1
Authority
AU
Australia
Prior art keywords
making
methods
same
dosage forms
oral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003256157A
Inventor
John Elgin Kerr
Allen Lee Lawson
Ranga Raju Namburi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of AU2003256157A1 publication Critical patent/AU2003256157A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003256157A 2002-08-05 2003-08-05 Oral dosage forms of water insoluble drugs and methods of making the same Abandoned AU2003256157A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40112102P 2002-08-05 2002-08-05
US60/401,121 2002-08-05
PCT/NL2003/000563 WO2004012714A1 (en) 2002-08-05 2003-08-05 Oral dosage forms of water insoluble drugs and methods of making the same

Publications (1)

Publication Number Publication Date
AU2003256157A1 true AU2003256157A1 (en) 2004-02-23

Family

ID=31495926

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003256157A Abandoned AU2003256157A1 (en) 2002-08-05 2003-08-05 Oral dosage forms of water insoluble drugs and methods of making the same

Country Status (3)

Country Link
EP (1) EP1539111A1 (en)
AU (1) AU2003256157A1 (en)
WO (1) WO2004012714A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005306464A1 (en) * 2004-11-18 2006-05-26 Bristol-Myers Squibb Company Enteric coated bead comprising Ixabepilone, and preparation thereof
AU2008291930B2 (en) * 2007-08-24 2014-04-17 Slotervaart Participaties Bv Compositions for the treatment of neoplastic diseases
GB0716591D0 (en) * 2007-08-24 2007-10-03 Vereniging Het Nl Kanker I Composition
US9089544B2 (en) 2007-08-24 2015-07-28 Slotervaart Participaties Bv Composition
CU23892B1 (en) * 2007-12-07 2013-04-19 Ct De Investigación Y Desarrollo De Medicamentos Cidem CYCLOSPORINE MICROENCAPSULATED PHARMACEUTICAL COMPOSITION A
JP2012500788A (en) * 2008-08-22 2012-01-12 スティヒティング ヘット ネーデルランド カンケル インスティテュート Composition
US20120035211A1 (en) * 2009-02-17 2012-02-09 Hetero Research Foundation Novel polymorphs of saquinavir
CN118059050A (en) * 2024-02-29 2024-05-24 杭州皓芽科技有限公司 Oral medicine with anticancer function and its processing method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249904T3 (en) * 1998-07-17 2006-04-01 Janssen Pharmaceutica N.V. GRANULATES THAT HAVE A COATED NUCLEUS WITH AN ANTI-FUNGICO AND A POLYMER.
US6673373B2 (en) * 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same

Also Published As

Publication number Publication date
EP1539111A1 (en) 2005-06-15
WO2004012714A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
HK1080481A1 (en) Phosphonooxy quinazoline derivatives and their pharmaceutical use
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
PL400027A1 (en) Multielement pharmaceutical dosage form and process for the preparation thereof
PL377854A1 (en) Nasal pharmaceutical formulations and methods of using the same
IL164463A (en) Use of osteoprotegerin in the preparation of medicaments
SG116507A1 (en) Pharmaceutical dosage form and method of making.
TWI319400B (en) Piperazinylacylpiperidine derivatives, their preparation and their therapeutic application
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003225285A1 (en) Oral dosage forms comprising fenofibrate
IL166337A0 (en) Oral administration of calctionin
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU2003284942A1 (en) Oral extended release tablets and methods of making and using the same
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
AU2003295713A1 (en) Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
AU2003240052A1 (en) Il-11 derivatives and therapeutic uses thereof
PL1663101T3 (en) Administration form and kit for the oral administration of active substances, vitamins and/or nutrients and use thereof
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof
GB0201607D0 (en) Formulation for the administration of medicinal substances
IL163431A (en) 1 - phenyl - 2 - heteroaryl - substituted benzimidazole derivatives and the use thereof for producing drugs used in the treatment of immunological diseases
AU2003245674A1 (en) Oral disease prevention and treatment
GB0208324D0 (en) Administration of beneficial substances
IL165843A0 (en) Popping oral administration form

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase